Chief Development Officer (Cdo)
CurrentChief Development Officer at Obsidian Therapeutics, a clinical stage biotechnology company pioneering engineered cell and gene therapies. Decades of experience designing, managing and leading complex cell and gene therapy clinical programs, including TIL therapies. Previously served as Senior Vice President, Clinical Science at Iovance Biotherapeutics and.